Literature DB >> 26502013

Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.

Maria Rubinstein1, Amer Assal1,2, Marina Scherba3, Jordan Elman2, Robert White4, Amit Verma1,2, Marianna Strakhan2,5, Farnoush Mohammadi2,5, Murali Janakiram1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26502013     DOI： 10.1002/ajh.24225

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

2.  Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report.

Authors:  Ting Liu; Xinxin Cao
Journal:  Ann Hematol       Date:  2021-11-06       Impact factor: 3.673

3.  [Rosai-Dorfman disease: a clinicopathologic analysis and whole exome sequencing in 23 cases].

Authors:  W J Fu; J Du; J Lu; L Z Wang; J M Yang; M X He; X X Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-08-14

4.  Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis.

Authors:  Daniel J Zinn; Olive Eckstein; Mary L Olsen; Carl E Allen; Kenneth L McClain
Journal:  Dermatol Case Rep       Date:  2019-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.